897 Stock Overview
Wai Yuen Tong Medicine Holdings Limited, an investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Wai Yuen Tong Medicine Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.23 |
| 52 Week High | HK$0.46 |
| 52 Week Low | HK$0.10 |
| Beta | 0.58 |
| 1 Month Change | -6.12% |
| 3 Month Change | -43.21% |
| 1 Year Change | -39.47% |
| 3 Year Change | -28.13% |
| 5 Year Change | -6.50% |
| Change since IPO | -100.00% |
Recent News & Updates
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding
Mar 11
The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business
Dec 28Recent updates
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding
Mar 11The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business
Dec 28Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?
Jul 11Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt
Jul 05Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?
Mar 08Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now
Aug 18Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?
Mar 17Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares
Jan 22Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?
Dec 16
Shareholder Returns
| 897 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.1% | 1.8% | 2.3% |
| 1Y | -39.5% | -17.4% | -10.9% |
Return vs Industry: 897 underperformed the Hong Kong Pharmaceuticals industry which returned -17.4% over the past year.
Return vs Market: 897 underperformed the Hong Kong Market which returned -10.9% over the past year.
Price Volatility
| 897 volatility | |
|---|---|
| 897 Average Weekly Movement | 16.2% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.5% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 897's share price has been volatile over the past 3 months.
Volatility Over Time: 897's weekly volatility has increased from 9% to 16% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1897 | 1,962 | Ching Ho Tang | www.wyth.net |
Wai Yuen Tong Medicine Holdings Limited, an investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong. The company manufactures, processes, and sells traditional Chinese medicines under the brand Wai Yuen Tong brand using selected medicinal materials with traditional prescriptions; and western pharmaceutical and personal care products under the Madame Pearl’s and Pearl’s brands. It also invests in commercial and industrial premises for rental; and offers management and sale of properties in agricultural produce exchange markets.
Wai Yuen Tong Medicine Holdings Limited Fundamentals Summary
| 897 fundamental statistics | |
|---|---|
| Market cap | HK$258.77m |
| Earnings (TTM) | HK$36.42m |
| Revenue (TTM) | HK$1.36b |
7.1x
P/E Ratio0.2x
P/S RatioIs 897 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 897 income statement (TTM) | |
|---|---|
| Revenue | HK$1.36b |
| Cost of Revenue | HK$703.11m |
| Gross Profit | HK$655.99m |
| Other Expenses | HK$619.57m |
| Earnings | HK$36.42m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.032 |
| Gross Margin | 48.27% |
| Net Profit Margin | 2.68% |
| Debt/Equity Ratio | 43.3% |
How did 897 perform over the long term?
See historical performance and comparison